Procter & Gamble Co (PG) Q1 2025 Earnings Call Highlights: Strong North American Growth Amid Global Challenges

Procter & Gamble Co (PG) reports a 2% organic sales growth and a 5% increase in core EPS, while navigating headwinds in Greater China and commodity costs.

Author's Avatar
4 days ago
Summary
  • Organic Sales Growth: 2% growth, with volume contributing 1 point and pricing adding 1 point.
  • Core Earnings Per Share (EPS): $1.93, up 5% versus prior year.
  • Core Operating Margin: Increased by 30 basis points, with a strong productivity improvement of 230 basis points.
  • Adjusted Free Cash Flow Productivity: 82%.
  • Cash Returned to Shareholders: Nearly $4.4 billion, including over $2.4 billion in dividends and over $1.9 billion in share repurchases.
  • North America Organic Sales Growth: 4%, driven by 4 points of volume growth.
  • Europe Focus Markets Organic Sales Growth: 3%, with a 4-point volume increase.
  • Greater China Organic Sales Decline: 15% due to weakened market conditions and brand-specific headwinds.
  • Core EPS Guidance for Fiscal 2025: Expected growth of 5% to 7%, equating to a range of $6.91 to $7.05 per share.
  • Commodity Cost Headwind: Approximately $200 million after tax, equating to $0.08 per share for fiscal 2025.
  • Expected Cash Return to Shareholders for Fiscal 2025: $16 billion to $17 billion, including $10 billion in dividends and $6 billion to $7 billion in share repurchases.
Article's Main Image

Release Date: October 18, 2024

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Procter & Gamble Co (PG, Financial) reported a 2% growth in organic sales, maintaining its guidance ranges for fiscal year 2025.
  • North America showed strong performance with a 4% growth in organic sales, driven by volume growth and broad-based market share gains.
  • Core earnings per share increased by 5% to $1.93, with a strong productivity improvement of 230 basis points.
  • The company returned nearly $4.4 billion of cash to shareholders, including $2.4 billion in dividends and $1.9 billion in share repurchases.
  • Procter & Gamble Co (PG) is focusing on innovation and superiority across its product lines, which is expected to drive future growth.

Negative Points

  • Organic sales in Greater China declined by 15%, with ongoing brand-specific headwinds, particularly affecting the SK-II brand.
  • The Asia-Pacific, Middle East, and Africa regions experienced soft market conditions, with organic sales down in low single digits.
  • The company faces a $200 million after-tax headwind from commodity costs, impacting its fiscal 2025 outlook.
  • There is concern about potential deceleration in markets where Procter & Gamble Co (PG) had previously shown strength, such as the US and Europe.
  • The baby care segment is under pressure due to declining birth rates, and the company needs to innovate to regain growth in this category.

Q & A Highlights

Q: How do you assess the challenges in markets like China and the Middle East, and what do you say to investors concerned about potential deceleration in stronger markets like the US and Europe?
A: Andre Schulten, CFO, acknowledged the challenges in China and the Middle East but emphasized the strength in the US, Canada, Europe, and Latin America, which constitute 85% of sales. These regions are growing at 4% on a high base, with strong innovation expected in the second half. The volatility is mainly due to China and the Middle East, and the guidance range reflects this uncertainty.

Q: Given the worsening trends in some markets, how confident are you in the stability of the 85% of your business not impacted by external factors?
A: Schulten expressed confidence in the stability of the 85% of the business, citing consistent growth in North America and Europe, and stabilizing trends in Latin America. He highlighted the company's focus on innovation and consumer engagement as key drivers for continued growth.

Q: Can you discuss the sustained category growth in the US and the market share momentum?
A: Schulten noted that the US market is expected to grow 3% to 4%, with P&G aiming to grow ahead of the market. He highlighted a $5 billion growth opportunity by serving underrepresented consumer groups and emphasized the importance of innovation in driving market growth and share gains.

Q: How do you view the impact of easing commodity costs on gross margins, and are there any factors that might offset this improvement?
A: Schulten stated that productivity will continue to drive gross margin progress, with a significant contribution from cost savings. While some easing of inflation is reflected, the majority will benefit the latter half of the fiscal year. SK-II's performance also impacts gross margins, and its stabilization will help.

Q: What are the expectations for improvement in China, and how do recent stimulus measures affect your outlook?
A: Schulten indicated that predicting recovery in China is challenging, but sequential improvement is expected as they annualize past impacts. The guidance range accounts for potential outcomes, with stabilization in China and the Middle East being key to reaching the midpoint of guidance.

Q: How do you address the divergence in performance across categories, particularly in beauty and baby care?
A: Schulten highlighted strong innovation in fabric and home care, which drives growth. In beauty, excluding China and SK-II, North America and Europe are performing well. For baby care, innovation and trading consumers up are key strategies to counteract declining birth rates.

Q: How are you managing market share performance, and what are the greatest areas of opportunity for improvement?
A: Schulten emphasized the importance of growing markets and increasing household penetration. He noted positive share trends in the US and Europe and highlighted innovation as a key driver for capturing market share.

Q: Can you provide an update on disruptive innovations like Olay Melts and Tide Evo?
A: Schulten reported that both Olay Melts and Tide Evo are performing well in test markets, with promising consumer reception. The company is progressing with industrialization to enable national launches, and further details on disruptive innovation will be shared at the upcoming Investor Day.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.